Hepatitis
Mahahalagang Punto
- Ang hepatitis ay pamamaga ng atay at iniuuri bilang acute (6 na buwan o mas maikli) o chronic (higit sa 6 na buwan).
- Kabilang sa karaniwang causes ang viral hepatitis (A-G), autoimmune hepatitis, at alcohol-, drug-, o toxin-related hepatic injury.
- Ang early findings ay maaaring nonspecific (fatigue, anorexia, nausea, pagsusuka); maaaring kabilang sa progression ang jaundice, RUQ pain, hepatomegaly, dark urine, at maputlang dumi.
- Ang severe disease ay maaaring magdulot ng ascites, hepatic encephalopathy, at bleeding risk mula sa impaired hepatic clotting-factor synthesis.
- Kabilang sa nursing priorities ang symptom support, serial laboratory monitoring, bleeding precautions, liver-protective teaching, at complication escalation.
Patopisyolohiya
Ang hepatitis ay nagdudulot ng hepatocellular inflammation at injury, na nagpapababa sa kakayahan ng atay na gampanan ang metabolic, synthetic, at detoxification functions. Ang persistent inflammation ay maaaring umusad sa fibrosis, cirrhosis, pagpalya ng atay, at sa ilang chronic viral forms, mas mataas na panganib ng hepatocellular carcinoma.
Ang nonviral hepatitis ay tumutukoy sa inflammatory liver injury na dulot ng alcohol, medications, toxins, o autoimmune disease sa halip na transmissible virus.
Classification
| Type | Typical route/cause | Chronic potential | Key nursing implications |
|---|---|---|---|
| Hepatitis A | Fecal-oral transmission (food/water contamination) | Usually acute/self-limited | Transmission hygiene, outbreak/travel prevention, vaccine counseling |
| Hepatitis B | Blood/body fluids, sexual, perinatal | Can become chronic | Monitor long-term complications; vaccine and exposure prevention teaching |
| Hepatitis C | Blood exposure (needles, nonsterile tattoo equipment, transfusion history), less often sexual/perinatal | Frequently chronic | Harm-reduction counseling and antiviral-treatment adherence |
| Hepatitis D | Requires HBV coinfection/superinfection | Depends on HBV status | Screen/manage with HBV context; higher severity risk |
| Hepatitis E | Contaminated water | Usually self-limited; may be severe in select patients | Water/sanitation teaching and supportive monitoring |
| Hepatitis G (HGV/GBV-C) | Blood/body-fluid exposure; occasional perinatal transmission | Usually low chronic injury burden | Often asymptomatic; monitor liver function and coinfection context with supportive care |
| Autoimmune hepatitis | Immune-mediated hepatocyte injury | Often chronic without control | Immunosuppressive therapy monitoring and relapse surveillance |
| Alcohol/drug-related hepatitis | Chronic alcohol misuse or hepatotoxic drug exposure | Can progress to liver failure | Abstinence support, medication review, and substance-use treatment referral |
Viral A/B/C Snapshot
| Type | Typical transmission | Approximate incubation | Typical pattern |
|---|---|---|---|
| Hepatitis A | Fecal-oral (contaminated food/water, close-contact spread) | 2-6 weeks | Often asymptomatic or mild self-limited illness with fatigue, appetite loss, nausea |
| Hepatitis B | Blood/body fluids, sexual, perinatal | 3-26 weeks | Can be acute or chronic; may progress to cirrhosis, liver failure, and hepatocellular carcinoma |
| Hepatitis C | Blood exposure (especially shared needles) | 2-33 weeks | Frequently undiagnosed early; high chronic-carrier risk with long-term fibrosis/cirrhosis risk |
Pagtatasa sa Nursing
- Tayahin ang symptom pattern:
- Early: anorexia, nausea, pagsusuka, fatigue (o asymptomatic presentation)
- Progressing: jaundice, RUQ pain, hepatomegaly, light-colored stool, dark urine
- Severe: ascites, altered mental status, bleeding signs
- I-monitor ang hemodynamic/fluid status: vital signs, 24-hour intake/output, daily weight, edema, abdominal girth.
- Tayahin ang perfusion at hydration: capillary refill, peripheral pulses, skin turgor, mucous membranes.
- Mag-screen para sa bleeding risk: hematuria, melena, ecchymosis, gum/IV-site oozing.
- I-trend ang laboratory at diagnostic data:
- ALT/AST, bilirubin, albumin
- PT/INR at iba pang coagulation indices
- Ammonia para sa encephalopathy risk
- Viral serologies at cause-specific testing
- Liver biopsy kapag kailangan ng kumpirmasyon ng etiology o lawak ng disease
Mga Interbensyon sa Nursing
- Magbigay ng supportive care: rest/activity pacing, hydration support, nutrition optimization gamit ang maliit at madalas na meals at pakikipag-collaborate sa dietician.
- Pigilan ang karagdagang liver injury:
- Iwasan ang hepatotoxic medications/substances (halimbawa acetaminophen/paracetamol, alcohol)
- Palakasin ang abstinence at substance-use treatment referral kapag indicated
- Ipatupad ang bleeding precautions: electric razor, soft oral care, fall/injury minimization, malapit na coagulation trend review.
- Pamahalaan ang symptom burden:
- Antiemetics at inutusang adjuncts para mapabuti ang intake
- Itch management gamit ang cool showers/baking soda baths at skin-protection measures
- Emotional support at nonjudgmental counseling
- I-monitor ang progression at maagang i-escalate para sa lumalalang confusion, severe abdominal distension, uncontrolled bleeding, o mga palatandaan ng pagpalya ng atay.
- Ituro ang transmission at self-management:
- Hand hygiene, huwag magbahagi ng personal items, environmental sanitation
- Risk-reduction para sa close contacts at vaccination counseling (HAV/HBV kung indicated)
- Follow-up laboratory adherence at return precautions
Pharmacology
| Category | Examples | Nursing considerations |
|---|---|---|
| Antivirals (chronic viral hepatitis) | Tenofovir, entecavir; DAA regimens for HCV | I-monitor ang adherence, liver labs, adverse effects, at treatment-response labs |
| Immunosuppressive therapy (autoimmune) | Corticosteroids and steroid-sparing agents | I-monitor ang infection risk, glucose, bone effects, at taper plans |
| Symptom/supportive medications | Antiemetics, nutritional supplements, selected anxiolytics | Gamitin nang maingat sa hepatic impairment; i-monitor ang sedation at hepatic metabolism burden |
| Vaccines/immunoprophylaxis | HAV/HBV vaccines; immune globulin for select exposures/contacts | Palakasin ang timing, risk groups, at post-exposure counseling |
Paglalapat ng Clinical Judgment
Klinikal na Sitwasyon
Isang kliyenteng may hepatitis ang nagkaroon ng tumataas na abdominal girth, bagong confusion, elevated PT/INR, at tumataas na ammonia.
- Recognize Cues: Ascites progression, altered cognition, coagulopathy, hyperammonemia.
- Analyze Cues: Lumalalang hepatic dysfunction na may mataas na panganib ng hepatic encephalopathy at pagdurugo.
- Prioritize Hypotheses: Ang agarang banta sa kaligtasan ay neurologic decline at hemorrhagic complications.
- Generate Solutions: I-escalate sa provider, magpatupad ng bleeding/fall precautions, i-trend ang critical labs, at maghanda ng inutusang therapies.
- Take Action: Paigtingin ang monitoring, ipatupad ang precautions, suportahan ang hemodynamics/nutrition, at palakasin ang family teaching.
- Evaluate Outcomes: Nagsi-stabilize ang mental status, nananatiling wala ang bleeding signs, at gumagaling o nagpa-plateau ang laboratory trends.
Mga Kaugnay na Konsepto
- hepatitis B - Virus-specific HBV transmission, serology, at chronic management.
- hepatitis C - HCV chronicity at DAA-focused cure pathway.
- ascites - Karaniwang severe complication ng advanced hepatic dysfunction.
- pagpalya ng atay - End-stage decompensation at transplant-level escalation.
- mga karamdaman sa paggamit ng substansiya - Recovery pathways para sa alcohol/drug-associated hepatitis risk.
Sariling Pagsusuri
- Aling findings ang nagpapahiwatig ng pag-usad mula sa early hepatitis tungo sa severe hepatic dysfunction?
- Bakit mahalagang i-trend ang PT/INR at ammonia labs sa advanced hepatitis?
- Anong client teaching ang nakababawas sa parehong transmission risk at future liver injury?